ArticleWorld journal of surgical oncology2024

Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.

Daolin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.